Level Four Advisory Services LLC cut its stake in shares of Danaher Co. (NYSE:DHR) by 25.6% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,160 shares of the conglomerate’s stock after selling 400 shares during the quarter. Level Four Advisory Services LLC’s holdings in Danaher were worth $202,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in DHR. Capital International Investors grew its holdings in shares of Danaher by 10.0% in the 1st quarter. Capital International Investors now owns 6,802,713 shares of the conglomerate’s stock worth $941,564,000 after acquiring an additional 619,550 shares during the last quarter. Bank of New York Mellon Corp grew its position in Danaher by 1.8% in the second quarter. Bank of New York Mellon Corp now owns 5,336,163 shares of the conglomerate’s stock worth $943,593,000 after acquiring an additional 96,524 shares in the last quarter. Legal & General Group Plc increased its stake in shares of Danaher by 6.1% during the 1st quarter. Legal & General Group Plc now owns 4,219,359 shares of the conglomerate’s stock worth $584,323,000 after purchasing an additional 241,613 shares during the last quarter. Fred Alger Management LLC raised its holdings in shares of Danaher by 4.6% during the 1st quarter. Fred Alger Management LLC now owns 3,508,036 shares of the conglomerate’s stock valued at $485,547,000 after purchasing an additional 155,156 shares in the last quarter. Finally, Pictet Asset Management Ltd. lifted its stake in shares of Danaher by 11.3% in the 1st quarter. Pictet Asset Management Ltd. now owns 3,461,644 shares of the conglomerate’s stock valued at $479,126,000 after purchasing an additional 351,689 shares during the last quarter. 78.01% of the stock is owned by institutional investors and hedge funds.
Shares of NYSE:DHR opened at $208.69 on Wednesday. Danaher Co. has a twelve month low of $119.60 and a twelve month high of $210.57. The firm has a market cap of $148.05 billion, a PE ratio of 44.69, a price-to-earnings-growth ratio of 3.22 and a beta of 0.91. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.74 and a current ratio of 2.20. The business has a fifty day moving average of $204.10 and a 200-day moving average of $171.62.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, September 28th will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.35%. Danaher’s payout ratio is 16.29%.
Several analysts have recently issued reports on DHR shares. Jefferies Financial Group upped their price target on Danaher from $190.00 to $230.00 and gave the stock a “buy” rating in a research note on Friday, July 24th. Royal Bank of Canada upped their price objective on shares of Danaher from $205.00 to $218.00 and gave the stock an “outperform” rating in a report on Friday, July 24th. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $195.00 target price for the company in a research report on Tuesday, June 16th. Needham & Company LLC lifted their price objective on Danaher from $183.00 to $209.00 and gave the stock a “buy” rating in a research note on Monday, July 27th. Finally, Bank of America increased their target price on Danaher from $181.00 to $215.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Danaher presently has an average rating of “Buy” and a consensus price target of $197.73.
In related news, Director Linda P. Hefner sold 2,754 shares of the firm’s stock in a transaction on Monday, July 27th. The stock was sold at an average price of $197.00, for a total transaction of $542,538.00. Following the sale, the director now owns 32,749 shares of the company’s stock, valued at approximately $6,451,553. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Angela S. Lalor sold 77,909 shares of the business’s stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $205.50, for a total value of $16,010,299.50. Following the completion of the transaction, the senior vice president now directly owns 52,445 shares of the company’s stock, valued at $10,777,447.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 530,474 shares of company stock valued at $104,501,669. Corporate insiders own 11.70% of the company’s stock.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
See Also: What are high-yield dividend stocks?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.